Mesa Laboratories Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	249.13	240.98	216.19	219.08	184.34
Revenue Growth (YoY)	3.38%	11.47%	-1.32%	18.85%	37.63%
Cost of Revenue	90.86	90.11	82.94	85.39	75.25
Gross Profit	158.27	150.87	133.25	133.69	109.09
Selling, General & Admin	119.45	115.02	111.49	109.88	88.62
Research & Development	20.31	19.52	19.3	20.49	15.77
Other Operating Expenses	-	-	274.53	-	-
Total Operating Expenses	139.76	134.53	405.33	130.37	104.39
Operating Income	18.51	16.34	-272.08	3.32	4.7
Interest Expense	-10.69	-11.86	-5.7	-4.77	-3.89
Other Non-Operating Income (Expense)	4.2	1.48	2.12	1.06	2.76
Total Non-Operating Income (Expense)	-6.5	-10.38	-3.57	-3.71	-1.13
Pretax Income	12.01	5.96	-275.65	-0.39	3.57
Provision for Income Taxes	5.3	7.94	-21.4	-1.32	1.7
Net Income	6.71	-1.97	-254.25	0.93	1.87
Net Income to Common	6.71	-1.97	-254.25	0.93	1.87
Net Income Growth	-	-	-	-50.29%	-42.85%
Shares Outstanding (Basic)	6	5	5	5	5
Shares Outstanding (Diluted)	6	5	5	5	5
Shares Change (YoY)	2.66%	0.65%	0.47%	0.49%	4.12%
EPS (Basic)	1.22	-0.36	-47.20	0.17	0.36
EPS (Diluted)	1.21	-0.36	-47.20	0.17	0.35
EPS Growth	-	-	-	-51.43%	-45.31%
Free Cash Flow	39.58	42.56	41.57	23.44	34.79
Free Cash Flow Growth	-7.00%	2.39%	77.34%	-32.63%	-0.83%
Free Cash Flow Per Share	7.11	7.85	7.72	4.37	6.52
Dividends Per Share	0.640	0.640	0.640	0.640	0.640
Gross Margin	63.53%	62.61%	61.64%	61.02%	59.18%
Operating Margin	7.43%	6.78%	-125.85%	1.52%	2.55%
Profit Margin	2.69%	-0.82%	-117.61%	0.42%	1.01%
FCF Margin	15.89%	17.66%	19.23%	10.70%	18.87%
EBITDA	41.78	40.86	-240.5	36.45	29.77
EBITDA Margin	16.77%	16.96%	-111.25%	16.64%	16.15%
EBIT	18.51	16.34	-272.08	3.32	4.7
EBIT Margin	7.43%	6.78%	-125.85%	1.52%	2.55%
Effective Tax Rate	44.13%	133.12%	7.76%	339.07%	47.65%

SEC Filings: 10-K · 10-Q